超低辐射剂量与对比剂用量CT协议及TAVI-CT评分用于TAVI规划与结局评估
回顾性纳入203例接受TAVI的患者,采用第三代双源CT行非增强及高螺距增强主动脉采集,评估CAD、CACS与AVCS,并与ICA比较。CAD诊断准确率89.0%,30天重度PAR患者AVCS更高,90天MACE患者AVCS与CACS更高,平均辐射剂量2.8±0.3 mSv。
要点
- 协议平均辐射剂量2.8±0.3 mSv,所有节段对比剂强化>500 HU且对比噪声比<20。
- CAD诊断准确率89.0%,半定性图像分析良好。
- 30天重度PAR患者AVCS更高,90天MACE患者AVCS与CACS更高。
核心结论
- 采用第三代双源CT的超低辐射剂量与对比剂用量TAVI规划协议可提供高诊断质量的图像,并完成CAD评估、AVCS与CACS定量,AVCS与CACS与TAVI结局相关。
研究设计与样本
- 回顾性研究,纳入203例接受TAVI并随访30天和90天的患者(131例男性,79.4±5.4岁),均行第三代2×192层双源CT,协议包括非增强及增强高螺距主动脉采集,CAD评估与ICA比较,采用非参数检验。
关键影像表现/征象
- 所有节段对比剂强化>500 HU,对比噪声比<20。
- 半定性图像分析结果为良好。
- 30天重度PAR患者AVCS显著更高。
- 90天MACE并发症患者AVCS为1904.5±621.3 HU(p<0.0001),CACS为769.2±365.5 HU(p<0.0230)。
诊断标准与关键数值
- CAD诊断准确率为89.0%。
- 对比剂强化阈值>500 HU,对比噪声比<20。
- AVCS与CACS以HU定量,分别与30天重度PAR及90天MACE相关。
临床应用与阅片要点
- 该协议可在超低辐射剂量与对比剂用量下完成TAVI规划及冠状动脉评估。
- AVCS与CACS定量结果与TAVI术后30天重度PAR及90天MACE相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the feasibility of an ultra-low radiation dose and contrast volume protocol using third-generation dual-source (DS) CT for transcatheter aortic valve implantation (TAVI) planning with coronary artery disease (CAD) assessment, coronary artery calcium score (CACS) and aortic valve calcium score (AVCS) quantification and to evaluate their relationship with TAVI outcome.
METHODS: In this retrospective study were selected 203 patients (131 males, 79.4 ± 5.4 years) underwent to TAVI and at 30- and 90-day follow-up. All patients had performed a third-generation 2 × 192-slices DSCT. The CT protocol included a non-contrast and a contrast high-pitch aortic acquisition for TAVI planning and CAD assessment. Semi-qualitative and quantitative image analysis were performed; the performance in CAD assessment was compared with ICA; the relationship between AVCS and CACS and paravalvular aortic regurgitation (PAR) and major cardiovascular events (MACEs) were evaluated. Mean radiation dose were calculated. Non-parametric tests were used.
RESULTS: Semi-qualitative image analysis was good. Contrast enhancement >500 Hounsfield unit (HU) and contrast-to-noise ratio <20 were obtained in all segments. The diagnostic accuracy in CAD was 89.0%. AVCS was significantly higher in patients with 30-day severe PAR. AVCS and CACS were higher in patients with 90-day MACE complications, respectively, 1904.5 ± 621.3 HU (p < 0.0001) and 769.2 ± 365.5 HU (p < 0.0230). Mean radiation dose was 2.8 ± 0.3 mSv.
CONCLUSION: A TAVI planning ultra-low radiation dose and contrast volume protocol using third-generation DSCT provides highly diagnostic images with CAD assessment, AVCS and CACS quantification and these latter were related with TAVI outcomes.
ADVANCES IN KNOWLEDGE: The proposed protocol using third-generation 2 × 192-slices DSCT allows with an ultra-low radiation dose and contrast volume the TAVI planning and the coronary artery assessment.
引用
- Fogante, Esposto Pirani, Cela, et al. Ultra-low radiation dose and contrast volume CT protocol and TAVI-CT score for TAVI planning and outcome. Br J Radiol. 2023. PMID: 37183830. doi:10.1259/bjr.20221026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。